{
    "code": 0,
    "data": [
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter & Nine Months December 2025",
            "news_body": "Outcome of Meeting",
            "news_id": "fb51628f-81b9-4fcf-84dd-d3a3158c9144",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80302ab0-7804-492b-ae4c-f7cddcc92967.pdf",
            "news_date": "2026-02-09 15:31:01",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Ended Quater September 2025",
            "news_body": "As per attachment",
            "news_id": "e9781c1c-7225-4309-aec3-92f71036c154",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265993f-3554-4004-9d0a-2861effa6779.pdf",
            "news_date": "2025-11-06 16:29:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "news_id": "58ff2e76-1e05-4edc-8b9f-5cde4f0042c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf",
            "news_date": "2025-11-06 16:25:32",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "news_id": "0a71de07-5e9e-42ca-bde8-058110ef9201",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11959022-3697-4e9d-9517-932286dd43f6.pdf",
            "news_date": "2025-08-01 15:22:49",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarter Ended 30Th June 2025",
            "news_body": "As per attachment",
            "news_id": "c9e806bd-03e2-482d-b8ae-d4a7ccc6b618",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1382030-78c7-4eef-a7c3-867ae9fd65b6.pdf",
            "news_date": "2025-08-01 12:35:32",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "news_id": "e075d53c-2e2c-47f8-9924-74d976f374fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c5b8816-0d2a-4289-9c0d-588f9f46e3fa.pdf",
            "news_date": "2025-05-13 16:29:41",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Meeting",
            "news_body": "outcome of meeting",
            "news_id": "ef598a9d-a7cf-45da-bb9b-fe66764f6479",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4590c00b-921d-4566-aed5-22db996e0397.pdf",
            "news_date": "2025-05-13 16:04:00",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Ouctome",
            "news_body": "outcome",
            "news_id": "d4d7d452-0267-4694-97a6-2c115783cd9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c890f688-407a-4563-be7f-47717ba8ddd0.pdf",
            "news_date": "2025-02-14 15:27:26",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financials Results For Quarter & Half Year Ended 30Th September 2024",
            "news_body": "outcome of meeting",
            "news_id": "63cf203c-b29b-4e5e-a04b-11301a855efc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d91ea356-37e8-40ac-b25f-2ecf13939fb2.pdf",
            "news_date": "2024-10-29 15:44:28",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For June 2024",
            "news_body": "Outcome of Meeting",
            "news_id": "23476937-1df0-4f50-acb9-04ba26664ffc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f41ff-ff4e-4ea2-a3ca-421fb7cd0ff4.pdf",
            "news_date": "2024-08-02 15:35:00",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "e82192cf-005d-4993-aac4-4e763c14b2e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe7defcb-06e2-4078-94ea-6d00b87116e8.pdf",
            "news_date": "2024-05-17 13:58:57",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months Ended 31 St December 2023",
            "news_body": "Unaudited Financial Results for third quarter and nine months ended 31st December 2023",
            "news_id": "3c31797b-709e-4fba-9fda-eb9673dd488a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9583a0a-dce2-46ff-b201-4663b167c6a5.pdf",
            "news_date": "2024-02-12 16:55:43",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Second Quarter & Half Year Ended 30Th September 2023",
            "news_body": "Unaudited financials Results for second quarter & half year ended 30th September 2023",
            "news_id": "0a1d6517-bc7d-4535-ab55-97037e959a72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b74c9dfc-3eae-448e-aec8-27a24d500426.pdf",
            "news_date": "2023-11-09 16:35:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2023",
            "news_body": "Unaudited Results for quarter ended 30th June 2023",
            "news_id": "c05268d3-07f6-4e3b-adb7-632067f1dc64",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaa49b3b-043d-4c26-8691-1b40b06210e3.pdf",
            "news_date": "2023-07-26 13:45:52",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2023<BR> <BR>",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2023<BR>  <BR>",
            "news_id": "ec9c01b5-e9a9-430b-8b72-e7f8d7d7d231",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be947997-bbb9-493b-ba8d-6834bdf09ba9.pdf",
            "news_date": "2023-07-26 13:43:34",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For Year Ended March 2023",
            "news_body": "Audited Results for year ended March 2023",
            "news_id": "f645da61-434d-4f1c-8638-f4404c4d3ca8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efc3fe99-e328-4251-8fe1-690601f597ca.pdf",
            "news_date": "2023-05-17 16:53:29",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board MEeting",
            "news_id": "3c9e3471-82ce-4238-b907-7429838ce206",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea99123-0315-4323-9ae3-e75593dc75cf.pdf",
            "news_date": "2023-05-17 16:51:57",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months 31St December 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter & nine months 31st December 2022",
            "news_id": "63429401-4ec4-483b-902b-5a5437c0b85d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e77c2646-e68f-453f-8f4c-ccae7e0236e6.pdf",
            "news_date": "2023-02-07 16:11:40",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months 31St December 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter & nine months 31st December 2022",
            "news_id": "289ad67d-407f-45c9-8a8c-42af2601c439",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73a06a68-28ef-4d7c-a142-8f77ec66f70d.pdf",
            "news_date": "2023-02-07 16:10:21",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose disclosure of Related Party Transactions for the half year endedSeptember 30, 2022.",
            "news_id": "1df3f809-3d92-4747-99fb-90b8ae05af32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52e06b90-1236-48ad-8c39-d3110b1ec95b.pdf",
            "news_date": "2022-11-22 11:49:21",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Second Quarter & Half Year Ended 30Th September 2022",
            "news_body": "Outcome of Board Meeting",
            "news_id": "dc68fff4-5303-4cc5-a5d3-28bebbb03a13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9567279f-83e2-4dab-a586-9f2b0cb45348.pdf",
            "news_date": "2022-11-11 16:08:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022",
            "news_id": "76f371d9-faa0-4acd-bc3a-2b3cabce18c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02f92110-ebd1-4865-b5bb-fb1db5d352d8.pdf",
            "news_date": "2022-07-25 17:41:35",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022",
            "news_id": "0b21d0fc-41d7-4d25-8753-feb42e20a637",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b53f19-a935-471e-a704-1568d7ff49da.pdf",
            "news_date": "2022-07-25 17:40:06",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions",
            "news_body": "Submission of Disclosure on Related Party Transactions",
            "news_id": "632da926-6e42-4f1c-a04b-a3d320c68d4f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a86eb839-e253-4483-81f0-73f513bd23ae.pdf",
            "news_date": "2022-05-30 22:10:42",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting",
            "news_body": "outcome of meeting",
            "news_id": "4f87a4f4-d72f-481d-ae1a-cbf5812bea22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a07fb38-a2f4-45a7-a385-57bd6f66c5e6.pdf",
            "news_date": "2022-05-16 16:37:02",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Year Ended 31St March 2022",
            "news_body": "outcome of meeting",
            "news_id": "83927c4d-ac78-4533-9395-f26983f199b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c2d17ae-d8e3-47b2-9298-4b6155466df9.pdf",
            "news_date": "2022-05-16 16:35:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ended 31St December 2021",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021",
            "news_id": "e9d7f1a5-f8c0-40a7-b225-b863b1e9a676",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcc3b893-44e0-42c5-b9ff-104195c5c2f2.pdf",
            "news_date": "2022-02-07 16:14:38",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ended 31St December 2021",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021",
            "news_id": "95f0ac7f-31ac-49d4-bc60-d17e8464d996",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3aa101e6-71e4-4b2c-94a2-b8f11f2e2f95.pdf",
            "news_date": "2022-02-07 16:12:49",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Un-Audited Standalone and Consolidated Financial Results and Limited Review Report<BR> for the quarter & half year ended 30th September 2021.",
            "news_id": "eec606b0-2514-4b00-8269-730872bbe0ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92b68e14-501c-43e3-a3d5-e3c8a0532d18.pdf",
            "news_date": "2021-10-29 16:42:38",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results And Limited Review Report For The Quarter & Half Year Ended 30Th September 2021",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "ae660426-49ae-4424-8fb2-852cc3d5d606",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d6722dd-f22c-4099-aef8-7ebc95ecdc6d.pdf",
            "news_date": "2021-10-29 16:41:02",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results And Limited Review Report For The Quarter Ended 30Th June 2021.<BR>",
            "news_body": "<BR> Pursuant to Clause 33 read with Clause 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone and Consolidated Financial Results and Limited Review Report for the quarter ended 30th June 2021.<BR>",
            "news_id": "8e8462c3-450f-451a-aa74-eceda4f28526",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b8b8ba5-4c7a-41cd-8bd6-323f8b7e2e10.pdf",
            "news_date": "2021-07-26 20:33:50",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions For 31St March 2021",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, we hereby submit the attached Related<BR> Party Transactions, on consolidated basis, drawn in accordance with applicable accounting standards for period ended 31st  March 2021",
            "news_id": "2e852b30-6cd7-473e-813d-f6ea7957c0cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c3750cd-a89f-4afa-a7fe-3701c013e0db.pdf",
            "news_date": "2021-06-15 16:10:30",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "965b3d02-1de5-4423-95ed-fd41b38fb07e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ddb78c9-0877-4767-9867-bb846a2e3ff6.pdf",
            "news_date": "2021-05-18 19:18:28",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter & Year Ended 31St March  2021.",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "bd5e5e24-58ce-437e-9d2f-3f65ab532ba0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a0bdb5-e494-422c-9344-ad2a5b10162f.pdf",
            "news_date": "2021-05-18 19:16:50",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}